Klaus Femmer

Title: Klaus Femmer: Innovator in Antiarrhythmic Compounds

Introduction

Klaus Femmer is a notable inventor based in Radebeul, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antiarrhythmic compounds. His work has implications for the treatment of heart rhythm disorders.

Latest Patents

Klaus Femmer holds a patent for "21-Deoxydihydroajmaline derivatives." This patent describes novel 21-deoxydihydroajmaline derivatives characterized by their antiarrhythmic activity. The compounds have the formula where R and R' are each the same alkyl group of 2 to 4 carbon atoms, or R and R' together with the associated nitrogen atom form a saturated 5- or 6-atom ring. The remaining atoms are either carbon or one oxygen atom, with X representing the anion of a physiologically inorganic or organic acid.

Career Highlights

Klaus Femmer has worked at Veb Arzneimittelwerk Dresden, where he has been involved in the research and development of pharmaceutical products. His expertise in medicinal chemistry has led to advancements in the field, particularly in the area of antiarrhythmic drugs.

Collaborations

Klaus Femmer has collaborated with notable colleagues such as Klaus Braun and Gunther Gabsch. These partnerships have fostered innovation and contributed to the success of their projects.

Conclusion

Klaus Femmer's contributions to the field of medicinal chemistry, particularly through his patent on antiarrhythmic compounds, highlight his role as an important inventor. His work continues to influence the development of effective treatments for heart rhythm disorders.